» Articles » PMID: 36653903

Awake Craniotomy for Operative Treatment of Brain Gliomas - Experience from University Medical Centre Ljubljana

Overview
Journal Radiol Oncol
Publisher Sciendo
Specialties Oncology
Radiology
Date 2023 Jan 18
PMID 36653903
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Awake craniotomy is a neurosurgical technique that allows neurophysiological testing with patient cooperation during the resection of brain tumour in regional anaesthesia. This allows identification of vital functional (i.e. eloquent) brain areas during surgery and avoidance of their injury. The aim of the study was to present clinical experience with awake craniotomy for the treatment of gliomas at the University Medical Centre Ljubljana from 2015 to 2019.

Patients And Methods: Awake craniotomy was considered in patients with a gliomas near or within the language brain areas, in all cases of insular lesions and selected patients with lesions near or within primary motor brain cortex. Each patient was assessed before and after surgery.

Results: During the 5-year period, 24 awake craniotomies were performed (18 male and 6 female patients; average age 41). The patient's cooperation, discomfort and perceived pain assessed during the awake craniotomy were in majority of the cases excellent, slight, and moderate, respectively. After surgery, mild neurological worsening was observed in 13% (3/24) of patients. Gross total resection, in cases of malignant gliomas, was feasible in 60% (6/10) and in cases of low-grade gliomas in 29% (4/14). The surgery did not have important negative impact on functional status or quality of life as assessed by Karnofsky score and Short-Form 36 health survey, respectively (p > 0.05).

Conclusions: The results suggest that awake craniotomy for treatment of gliomas is feasible and safe neurosurgical technique. The proper selection of patients, preoperative preparation with planning, and cooperation of medical team members are necessary for best treatment outcome.

Citing Articles

Synergistic Effects of Neratinib in Combination With Palbociclib or Miransertib in Brain Cancer Cells.

Mulliqi E, Khelwatty S, Morgan A, Ashkan K, Modjtahedi H World J Oncol. 2024; 15(3):492-505.

PMID: 38751701 PMC: 11092418. DOI: 10.14740/wjon1873.


An update on tests used for intraoperative monitoring of cognition during awake craniotomy.

de Zwart B, Ruis C Acta Neurochir (Wien). 2024; 166(1):204.

PMID: 38713405 PMC: 11076349. DOI: 10.1007/s00701-024-06062-6.

References
1.
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J, Pujol S . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012; 30(9):1323-41. PMC: 3466397. DOI: 10.1016/j.mri.2012.05.001. View

2.
DeAngelis L . Brain tumors. N Engl J Med. 2001; 344(2):114-23. DOI: 10.1056/NEJM200101113440207. View

3.
Joswig H, Bratelj D, Brunner T, Jacomet A, Hildebrandt G, Surbeck W . Awake Craniotomy: First-Year Experiences and Patient Perception. World Neurosurg. 2016; 90:588-596.e2. DOI: 10.1016/j.wneu.2016.02.051. View

4.
LaPointe S, Perry A, Butowski N . Primary brain tumours in adults. Lancet. 2018; 392(10145):432-446. DOI: 10.1016/S0140-6736(18)30990-5. View

5.
Bunevicius A . Reliability and validity of the SF-36 Health Survey Questionnaire in patients with brain tumors: a cross-sectional study. Health Qual Life Outcomes. 2017; 15(1):92. PMC: 5418840. DOI: 10.1186/s12955-017-0665-1. View